Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Follow-Up Questions
What is Kamada Ltd (KMDA)'s P/E Ratio?
The P/E ratio of Kamada Ltd is 26.9194
What is the price performance of KMDA stock?
The current price of KMDA is $6.78, it has decreased 1.52% in the last trading day.
What are the primary business themes or industries for Kamada Ltd?
Kamada Ltd belongs to Biotechnology industry and the sector is Health Care
What is Kamada Ltd market cap?
Kamada Ltd's current market cap is $391.3M
Is Kamada Ltd a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Kamada Ltd, including 3 strong buy, 5 buy, 1 hold, 0 sell, and 3 strong sell
